Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China

6 Sept 2024

Abstract excerpt

BACKGROUND: Patients with mucopolysaccharidosis (MPS) often face delayed diagnoses, limited treatment options and high healthcare costs, that may significantly affect patients' quality of life. The objective of this study was to understand medical service utilization related to diagnosis and treatment, economic burden during diagnosis period, and health-related quality of life among MPS patients in China....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lysosomal Storage Disorders Research
Share to Parasitic Diseases Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39243096
DOI: 10.1186/s13023-024-03333-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in ChinaPMID 39243096Read ↗

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)Semantic proximity Read ↗

Epidemiology of Mucopolysaccharidoses UpdateSemantic proximity Read ↗

The diagnosis and management of mucopolysaccharidosis type IISemantic proximity Read ↗

Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey studySemantic proximity Read ↗

Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory DiagnosisSemantic proximity Read ↗

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseSemantic proximity Read ↗

Prevalence rates of mucopolysaccharidosis in Iraq: a retrospective cross-sectional observational studySemantic proximity Read ↗

A Review Of The Clinical Outcomes In Idursulfase-Treated And Untreated Filipino Patients With Mucopolysaccharidosis Type II: Data From The Local Lysosomal Storage Disease RegistrySemantic proximity Read ↗

Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes.Semantic proximity Read ↗

Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period.Semantic proximity Read ↗

The Landscape of Mucopolysaccharidosis in Southern and Eastern European Countries: A Survey from 19 Specialistic Centers.Semantic proximity Read ↗

The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.